Annexon Biosciences (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- June 23, 2016
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $44,000,000
Company Info
- Organizations Involved
- Adage Capital Management, Bain Capital, Blackstone, New Enterprise Associates, Novartis Venture Funds, Satter Investment Management, Surveyor Capital
- Company Description
- Annexon Biosciences is pioneering the development of first-in-class therapeutic products that halt the progression of complement-mediated neurodegeneration (CMND). Backed by a team of experts in CMND, Annexon's mission is to rapidly advance disease-modifying therapies for patients with acute and chronic neurodegenerative disorders.
- Market
- Neurodegenerative Disorders
- Location
- South San Francisco, California, USA
- Coinvestors
- Clarus Ventures, Correlation Ventures, Novartis Venture Funds, Satter Investment Management